BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 110564
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.110564
Figure 5
Figure 5 Assessment of senescence and migration in induced pluripotent stem cells-derived mesenchymal stem cell lines. A: Representative micrographs of senescence in induced pluripotent stem cells-derived mesenchymal stem cell (iMSC) lines compared to bone marrow mesenchymal stem cells (BM-MSCs) (control), scale bar = 200 μm; B: Quantification of senescence-associated beta-galactosidase-positive cells in iMSCs; C: Representative microscopic images showing wound closure in iMSC lines compared to BM-MSCs at 0, 6, 24, and 48 hours post-scratch, scale bar = 200 μm; D: Quantification of migration area over time presented as bar graphs. Data are presented as mean ± SE from at least three independent biological replicates. bP ≤ 0.01; cP ≤ 0.001; dP ≤ 0.0001. BM-MSCs: Bone marrow mesenchymal stem cells; EB-iMSCs: Embryoid body-induced pluripotent stem cells-derived mesenchymal stem cells; iMSC: Induced pluripotent stem cells-derived mesenchymal stem cell; SA-β Gal: Senescence-associated beta-galactosidase.


Write to the Help Desk